FDA inspection
Lung Bioengineering Inc.: FDA inspection ending Feb 12, 2018
FDA inspection 1041025 · No Action Indicated (NAI) · Silver Spring, MD
Key facts
| Inspection ID | 1041025 |
|---|---|
| Firm | Lung Bioengineering Inc. |
| FEI number | 3013113864 |
| Address | 1015 Spring St |
| City | Silver Spring |
| State | MD |
| ZIP | 20910 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Feb 12, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data